FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Mary Alma Welch

Research Profile

Disorders

Chemicals & Drugs

Procedures

Activities & Behaviors

Occupations

Cytogenetics

Co-author Network

Publications

TOP 3
Megan Cornelison; Elias Jabbour; Mary Alma Welch
Managing side effects of tyrosine kinase inhibitor therapy to optimize adherence in patients with chronic myeloid leukemia: the role of the midlevel practitioner.
A Megan Cornelison; Charles Koller; Mary Alma Welch; Elias Jabbour
Dasatinib combined with interferon-alfa induces a complete cytogenetic response and major molecular response in a patient with chronic myelogenous leukemia harboring the T315I BCR-ABL1 mutation.
Yesid Alvarado; Mary Alma Welch; Ronan Swords; John Bruzzi; Ellen Schlette; Francis Giles
Nelarabine activity in acute biphenotypic leukemia.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Mary Alma Welch (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Megan Cornelison; Elias Jabbour; Mary Alma Welch
Managing side effects of tyrosine kinase inhibitor therapy to optimize adherence in patients with chronic myeloid leukemia: the role of the midlevel practitioner.
The journal of supportive oncology 2012;10(1):14-24.
2011: A Megan Cornelison; Charles Koller; Mary Alma Welch; Elias Jabbour
Dasatinib combined with interferon-alfa induces a complete cytogenetic response and major molecular response in a patient with chronic myelogenous leukemia harboring the T315I BCR-ABL1 mutation.
Clinical lymphoma, myeloma & leukemia 2011;11 Suppl 1():S111-3.
2007: Yesid Alvarado; Mary Alma Welch; Ronan Swords; John Bruzzi; Ellen Schlette; Francis Giles
Nelarabine activity in acute biphenotypic leukemia.
Leukemia research 2007;31(11):1600-3.
2006: Karen W L Yee; Sharon R Hymes; Lior Heller; Victor G Prieto; Mary Alma Welch; Francis Giles
Cutaneous leukocytoclastic vasculitis in a patient with myelodysplastic syndrome after therapy with the rapamycin analogue everolimus: case report and review of the literature.
Leukemia & lymphoma 2006;47(5):926-9.
2004: Patricia Ault; Andrew Lamb; Mary Alma Welch; Francis Giles; Mary Beth Rios; Jorge Cortes
Interleukin 11 May improve thrombocytopenia associated with imatinib mesylate therapy in chronic Myelogenous leukemia.
Leukemia research 2004;28(6):613-8.
2003: Apostolia-Maria Tsimberidou; Dawn E Colburn; Mary Alma Welch; Jorge E Cortes; Srdan Verstovsek; Susan M O'Brien; Maher Albitar; Hagop M Kantarjian; Francis Giles
Anagrelide and imatinib mesylate combination therapy in patients with chronic myeloproliferative disorders.
Cancer chemotherapy and pharmacology 2003;52(3):229-34.
2002: Dawn E Colburn; Mary Alma Welch; Francis Giles
Skin infiltration with chronic lymphocytic leukemia is consistent with a good prognosis.
Hematology (Amsterdam, Netherlands) 2002;7(3):187-8.